Sylvia Franc

Corbeil-essonnes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Association of eating disorders and/or insulin omission with impaired glycaemic control in persons living with type 1 diabetes: cross-sectional analysis of the French SFDT1 study.

Association of eating disorders and/or insulin omission with impaired glycaemic control in persons living with type 1 diabetes: cross-sectional analysis of the French SFDT1 study.

Journal: BMJ open

Published: March 19, 2026

Safety and glycemic outcomes of DBLG1 coupled to the DANA-i pump in adults and adolescents with type 1 diabetes mellitus. The SP8 trial.

Safety and glycemic outcomes of DBLG1 coupled to the DANA-i pump in adults and adolescents with type 1 diabetes mellitus. The SP8 trial.

Journal: Journal of endocrinological investigation

Published: July 23, 2025

Hybrid Closed Loop in Adolescents and Young Adults Living with Type 1 Diabetes: A Real-World Study.

Hybrid Closed Loop in Adolescents and Young Adults Living with Type 1 Diabetes: A Real-World Study.

Journal: Diabetes technology & therapeutics

Published: April 10, 2025

Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort.

Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort.

Journal: Cardiovascular diabetology

Published: March 14, 2025

Practical implementation of automated insulin delivery systems in 2025: A French position statement update.

Practical implementation of automated insulin delivery systems in 2025: A French position statement update.

Journal: Diabetes & metabolism

Published: February 08, 2025

Optimization of insulin management during postprandial and post-absorptive exercise in adults with type 1 diabetes: DiabraAlgo effectiveness in real life ?

Optimization of insulin management during postprandial and post-absorptive exercise in adults with type 1 diabetes: DiabraAlgo effectiveness in real life ?

Journal: Diabetes research and clinical practice

Published: January 12, 2025

Emotional distress as a therapeutic target against persistent poor glycaemic control in subjects with type 1 diabetes: A systematic review.

Emotional distress as a therapeutic target against persistent poor glycaemic control in subjects with type 1 diabetes: A systematic review.

Journal: Diabetes, obesity & metabolism

Published: December 10, 2024

Monoallelic pathogenic variants in LEPR do not cause obesity.

Monoallelic pathogenic variants in LEPR do not cause obesity.

Journal: American journal of human genetics

Published: August 19, 2024

Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens.

Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens.

Journal: Diabetes technology & therapeutics

Published: May 17, 2024

Functional genetics reveals the contribution of delta opioid receptor to type 2 diabetes and beta-cell function.

Functional genetics reveals the contribution of delta opioid receptor to type 2 diabetes and beta-cell function.

Journal: Nature communications

Published: January 23, 2024

Exploring the role of purinergic receptor P2RY1 in type 2 diabetes risk and pathophysiology: Insights from human functional genomics.

Exploring the role of purinergic receptor P2RY1 in type 2 diabetes risk and pathophysiology: Insights from human functional genomics.

Journal: Molecular metabolism

Published: October 12, 2023

Pathogenic, Total Loss-of-Function DYRK1B Variants Cause Monogenic Obesity Associated With Type 2 Diabetes.

Pathogenic, Total Loss-of-Function DYRK1B Variants Cause Monogenic Obesity Associated With Type 2 Diabetes.

Journal: Diabetes care

Published: October 02, 2023

Showing 1-12 of 63

Last Updated: 09/26/2026